Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2002-3-7
pubmed:abstractText
Previous studies demonstrated a relationship between the degree of insulin resistance and plasma plasminogen activator inhibitor type-1 (PAI-1) levels. We aim at investigating the relationship between the degree of insulin resistance and plasma PAI-1 levels in aged subjects (n=83) and in healthy centenarians (n=42). In all subjects the degree of insulin resistance was assessed by HOMA method. Our data demonstrated that healthy centenarians have higher plasma PAI-1 levels (73.1+/-13.9 vs 23.7+/-14.7 ng/ml, P<0.001) and lower degree of insulin resistance (1.4+/-0.5 vs 3.3+/-1.3, P<0.001) than aged subjects. In aged subjects plasma PAI-1 levels correlated with the degree of insulin resistance (r=0.61, P<0.001), fasting plasma triglycerides (r=0.74, P<0.001) and age (r=0.33, P<0.001). All such associations were lost in centenarians. Plasma PAI-1 Ag levels were also similar in aged subjects and centenarians even after categorization for PAI gene polymorphism. In multivariate analysis, a model made by age, sex, body mass index, fasting plasma triglycerides, HOMA and PAI-1 gene explained 65 and 50% of plasma PAI-1 level variations in aged subjects and centenarians, respectively. Nevertheless, HOMA (P<0.001) was significantly and independently associated with plasma PAI-1 levels only in aged subjects. In conclusion, our data demonstrates that in healthy centenarians, plasma PAI-1 were not associated with the degree of insulin resistance as in aged subjects. Frequency of PAI-1 genotype does not provide an explanation for such differences between aged subjects and centenarians.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0021-9150
pubmed:author
pubmed:issnType
Print
pubmed:volume
160
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
385-90
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed-meshheading:11849662-Adult, pubmed-meshheading:11849662-Aged, pubmed-meshheading:11849662-Aged, 80 and over, pubmed-meshheading:11849662-Aging, pubmed-meshheading:11849662-Antifibrinolytic Agents, pubmed-meshheading:11849662-Antithrombin III, pubmed-meshheading:11849662-Body Mass Index, pubmed-meshheading:11849662-Female, pubmed-meshheading:11849662-Fibrinolysin, pubmed-meshheading:11849662-Genotype, pubmed-meshheading:11849662-Humans, pubmed-meshheading:11849662-Insulin Resistance, pubmed-meshheading:11849662-Male, pubmed-meshheading:11849662-Peptide Hydrolases, pubmed-meshheading:11849662-Plasminogen Activator Inhibitor 1, pubmed-meshheading:11849662-Polymerase Chain Reaction, pubmed-meshheading:11849662-Polymorphism, Genetic, pubmed-meshheading:11849662-Reference Values, pubmed-meshheading:11849662-Triglycerides, pubmed-meshheading:11849662-alpha-2-Antiplasmin
pubmed:year
2002
pubmed:articleTitle
Elevated plasma activator inhibitor 1 is not related to insulin resistance and to gene polymorphism in healthy centenarians.
pubmed:affiliation
Department of Geriatric Medicine and Metabolic Diseases, IV Divisione di Medicina Interna, Second University of Naples, Piazza Miraglia, 2, 80138 Naples, Italy.
pubmed:publicationType
Journal Article